Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03951363 · ClinicalTrials.gov registry record · NA
iControl Chronic Kidney Disease
A NA study, sponsored by Duke University.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT03951363 is a NA study that was terminated before completion, run by Duke University. The registered enrollment target is 4 participants.
The verdict
NCT03951363, a NA study, was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The proposed study is responsive to the call for obtaining enhanced preliminary data for an external grant resubmission. The goal is to demonstrate a novel approach using digital health tools to help preserve kidney function. The investigators aim to adapt a previous behavioral intervention and conduct formative testing among patients with CKD. Specifically, the investigators will: Aim 1: Modify an existing technology platform to build the iControl CKD system and adapt intervention content to reflect behavioral guidelines for patients with mild to moderate CKD. Aim 2: Conduct qualitative interviews and user testing among patients with CKD to obtain feedback on the design of the intervention. Aim 3: Conduct a prospective cohort feasibility trial to assess the feasibility and initial acceptability of the iControl CKD intervention.
Interventions
- BEHAVIORAL interactive Obesity Treatment Approach (iOTA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2019-05-13 |
| Est. Completion | 2020-02-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03951363
The ClinicalTrials.gov registry entry for NCT03951363 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which interactive Obesity Treatment Approach (iOTA) is the first listed.
NCT03951363 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03951363 about?
NCT03951363 is a clinical study titled "iControl Chronic Kidney Disease". The proposed study is responsive to the call for obtaining enhanced preliminary data for an external grant resubmission. The goal is to demonstrate a novel approach using digital health tools to help preserve kidney function. The investigators aim to adapt a previous behavioral intervention and cond...
What is the current status of trial NCT03951363?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2019-05-13. Estimated completion is 2020-02-20.
What interventions are being tested in trial NCT03951363?
The interventions under investigation include: interactive Obesity Treatment Approach (iOTA) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03951363?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.